title: Organ procurement organization compliance with 21 CFR 1271: a challenge for allogeneic pancreatic islet cell transplantation programs.
abstract: In order to protect tissue recipients, the Food and Drug Administration drafted Title 21, Section 1271 of the Code of Federal Regulations 1271 (21 CFR 1271) to address infectious disease risk. These regulations apply to tissues but not vascularized organs. Pancreatic islet cells are regulated under 21 CFR 1271. These regulations require qualification of suppliers of critical materials and services with regard to 21 CFR 1271 compliance. As part of supplier qualification, all organ procurement organizations (OPOs) in the United States were sent a questionnaire covering the key components of these regulations. Of the 57 OPOs, 29 (51%) were in compliance based upon survey results. Twelve (21%) were not compliant in one or more areas. All indicated plans to become compliant. The remaining 15 (27%) either failed or refused to complete the survey, some indicating 21 CFR 1271 did not apply to OPOs. Using 2006 data, OPOs compliant with 21 CFR 1271 recovered 50% of the organs procured in the United States. These findings represent a challenge for allogeneic islet cell transplant programs whose raw material must comply with 21 CFR 1271. OPOs should work toward understanding and complying with 21 CFR 1271. Regulatory agencies should work toward enhancing safety of the pancreas supply by facilitating compliance through harmonization of requirements.
authors.affiliation: Division of Transfusion Medicine, Mayo Clinic, Rochester, MN, USA. winters.jeffrey@mayo.edu
authors.forename: J L
authors.initials: JL
authors.lastname: Winters
authors.forename: S A
authors.initials: SA
authors.lastname: Tran
authors.forename: D A
authors.initials: DA
authors.lastname: Gastineau
authors.forename: D J
authors.initials: DJ
authors.lastname: Padley
authors.forename: P G
authors.initials: PG
authors.lastname: Dean
authors.forename: Y C
authors.initials: YC
authors.lastname: Kudva
mesh_terms: D002102:Cadaver; D018562:Disease Transmission, Infectious / Q000517:prevention & control; D006801:Humans; D016381:Islets of Langerhans Transplantation / Q000331:legislation & jurisprudence*; D014015:Tissue Banks / Q000331:legislation & jurisprudence* / Q000592:standards; D014019:Tissue Donors / Q000331:legislation & jurisprudence; D009927:Tissue and Organ Procurement / Q000331:legislation & jurisprudence* / Q000458:organization & administration / Q000592:standards; D014184:Transplantation, Homologous; D014481:United States; D014486:United States Food and Drug Administration; D014488:United States Health Resources and Services Administration